Figure 1: Imaging of amyloid-β deposits in the live mouse. Figure 3: In vivo imaging of amyloid-β deposits in 20-month-old homozygous PDAPP mice. Immunostaining with biotinylated or ...

For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...

noninvasive method that provides information about the distribution and extent of amyloid deposit throughout the body. This is a highly conserved invariant plasma glycoprotein that, as a result of ...

A recent study has revealed a surprising connection between a seemingly harmless habit—nose picking—and the potential risk of ...

A study published in 2022 revealed a tenuous but plausible link between picking your nose and increasing the risk of ...

Medically reviewed by Anita C. Chandrasekaran, MD Hereditary transthyretin (hATTR) amyloidosis is a rare progressive disease ...

Amyloid deposit in the cardiac allograft was reported as early as 5 months and as late as 60 months. [26] The UK Experience concluded that recurrence of amyloid in the transplanted heart is common ...

It occurs when an abnormal protein, called amyloid, builds up and forms deposits in the body. Amyloidosis is closely linked to MM. Amyloid light chain (AL) amyloidosis is the most common type of ...

Microglia can partially break down amyloid plaques by "spitting" a digestive enzyme at them, a new study has found.

The Alzheimer’s epidemic continues to cast a shadow over the lives of millions. This disease erodes memories and cognitive ...

ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on developing precision therapies for neurodegenerative diseases, today announced the initiation of its Phase 1b ...